Navigation Links
Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
Date:5/15/2013

SAN DIEGO, May 15, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the first quarter ended March 31, 2013, and reported on highlights and other recent developments including:

  • Awarded ISO 13485 Certification for Excellagen, State of California manufacturing license and state clearances to market and sell Excellagen in the U.S., and advanced other international registrations for Excellagen, including CE Mark registration, which the Company expects to receive approval on or around the end of the second quarter 2013. 
  • Announced sales and distribution agreement with Academy Medical, LLC to market, sell and distribute Excellagen to U.S. government medical providers.  Academy Medical has a growing customer base of over 35 Veterans Administration and military hospitals within the U.S.  Cardium also entered agreements with independent regional distributor groups with sales representatives focused on podiatry, orthopedic physicians, plastic surgeons, hospitals and surgical centers. Including Academy Medical, there are currently over 60 sales representatives selling Excellagen. 
  • Excellagen awarded the American Podiatric Medical Association's Seal of Approval for its contributions to better foot health and mobility.
  • Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting highlighting Excellagen's capability of promoting rapid granulation and complete healing in three difficult and complex post-surgical wounds, including Mohs surgery and wound dehiscence.
  • Presentation at the 2013 Phacilitate Annual Cell & Gene Therapy Forum in Washington, DC, "Optimizing Phase III Trial Design for Generx® (Ad5FGF-4)" reporting on adaptive coronary collateral growth, the biological processes to be targeted by therapeutic angiogenesis, and discussed the lessons
    '/>"/>

  • SOURCE Cardium Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Cardium Announces Generx Publication In Molecular Therapy
    2. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
    3. Cardium Presents Year-End 2012 Financial Results And Recent Developments
    4. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
    5. Cardium Receives ISO Certification for Excellagen
    6. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
    7. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
    8. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
    9. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
    10. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
    11. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)...  Over 200 runners participated in the fifth annual ... Oncology Institute (ROI), hosted by Radiation Business Solutions. This year ... San Francisco.  "Donations are still coming ... Business Solutions, "but at this point, through registrations ... the ROI this year. This surpasses last year,s record ...
    (Date:9/19/2014)... and CAMBRIDGE, Mass. , Sept. 19, ... (PGDx), a provider of advanced cancer genome analysis ... a leader in discovering and developing highly selective ... the first-ever comprehensive genomic study of malignant mixed ... of the female reproductive system, also known as ...
    (Date:9/18/2014)... , September 19, 2014 ... Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced the ... Market 2014-2018" report to their offering. ... Cytogenetics involves the study of chromosomes using ... functions of genes and chromosomes. It plays ...
    Breaking Medicine Technology:Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
    ... , , AUSTIN, Texas, Sept. ... be at the forefront of ending Paralysis. WillWalk will raise $3 million ... with Spinal Cord Injury (SCI). , , The money ... U.S. The stem cells being used are a non-controversial adult stem cell ...
    ... , , SAN DIEGO, Sept. ... studies of DAS181 activity against H1N1 influenza and NAI-resistant influenza ... (ICAAC) meeting on Sunday, September 13, 2009, in San Francisco, ... at the Centers for Disease Control and Prevention (CDC), University ...
    Cached Medicine Technology:Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 2NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009 2NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009 3
    (Date:9/19/2014)... California (PRWEB) September 19, 2014 ... by technological advancements, surgical techniques, and immunosuppressant drugs ... preferred treatment for several chronic diseases related to ... in organ and tissue transplantation have phenomenally revolutionized ... Organ transplant today represents a pivotal medical ...
    (Date:9/19/2014)... grow well in infertile land, and bear many beans ... is because most legumes have a symbiotic relationship with ... air and then supply the host plant with ammonia ... organs called nodules in their roots. However, if too ... the growth of the plants, because the energy cost ...
    (Date:9/19/2014)... Lifeinsure.biz has released a new ... can be purchased without medical examinations. , Life ... a life insurance policy more advantageous. Clients can read ... extra options available for a no medical exam life ... required is simple to purchase, however it is more ...
    (Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... Stevie Wonder tickets for his 2014 concert tour. ... In the music business, there are a handful of artists ... Stevie Wonder. Born in Saginaw, MichIgan, Wonder has been a ... During his time in the music business, he has released ...
    (Date:9/19/2014)... Dr. John Paul Gallardo and Dr. William ... Miami practice. Routinely at the forefront of cutting-edge ... are one of the first dentistry teams in the ... and treating periodontal disease. , Periodontal disease ... diseases in the world. The United State’s Surgeon ...
    Breaking Medicine News(10 mins):Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Long-distance communication from leaves to roots 2Health News:No Medical Exam Life Insurance - Lifeinsure.biz Presents 5 Important Riders! 2Health News:Stevie Wonder Tickets: Ticket Down Slashes Ticket Prices in Seattle, Boston, New York, Atlanta, Chicago, Detroit, Philadelphia, Toronto, Las Vegas & Oakland 2Health News:Stevie Wonder Tickets: Ticket Down Slashes Ticket Prices in Seattle, Boston, New York, Atlanta, Chicago, Detroit, Philadelphia, Toronto, Las Vegas & Oakland 3Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 3
    ... with breast cancer are more likely to have traces ... of the fungicide hexachlorobenzene (HCB) were present in them. ... HCB actually cause breast cancer. The pesticides banned in ... in developing countries. DDT, HCB and other environmental endocrine ...
    ... members were confirmed as SARS patients. The doctors quarantined the ... the first major occurrence of SARS in India. The bride's ... positive for the illness after traveling to Maharashtra state from ... for SARS during the journey. //The man, a cloth merchant ...
    ... and Wellness Foundation is predicting a 300pc rise in the ... experts say this figure is possibly a little high. In ... an epidemic of type two diabetes is to occur. If ... disease, blindness and kidney failure. It is also estimated that ...
    ... number two cause of cancer death among American men. ... definitive local therapy, prostate cancer recur in 21% of ... whether the disease is localized or includes distant metastases. ... PSA has proven the most effective way to detect ...
    ... in which blood glucose levels are above normal. People ... is broken down into a sugar called glucose, which ... body. Cells use the hormone insulin, made in the ... People with diabetes can prevent or delay complications by ...
    ... with diabetes should not take hormone replacement therapy. Researchers in ... HRT increase their chances of dying early. Researchers also said ... disease or having a heart attack. They studied 13,084 women ... had taken HRT. They found that women with diabetes who ...
    Cached Medicine News:
    Intermittent catheter...
    Intermittent catheter...
    The SJM Sguin annuloplasty ring, a semi-rigid ring, is constructed of a one-piece solid core of ultra-high-weight polyethylene enclosed in a knitted polyester sewing cuff....
    ... Welcome to a new dimension ... a liquid tool composed of purified ... surgical capabilities. Perfluoron is ideal for ... vitreoretinopathy, giant retinal tears and trauma. ...
    Medicine Products: